Clinical Trials Directory

Trials / Completed

CompletedNCT01977157

Alcohol Detection Via Bioimpedance Mesurements

Status
Completed
Phase
Study type
Observational
Enrollment
12 (actual)
Sponsor
RWTH Aachen University · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Examination if the bioimpendanz measurement can be used for the determination of the alcohol content in human blood. Furthermore the blood alcohol content (BAC) will be estimated by an official breathalyzer and one blood test.

Detailed description

In this clinical trail it will be analyzed, if it is possible to assess the blood alcohol content (BAC) with the bioimpedance devices (SFB7, ImpediMed; Nicomo). This technology is non-invasive an can be measured by using conductive electrodes, capacitive electrodes or inductive measurement systems. The BIS-values will be compared with an official breathanalyzer (Alcotest 7110 Evidential MK III, Dräger, Lübeck, Germany). Furthermore one blood sample will be taken and analyzed with the ADH method as the current gold standard at the end of the trail.

Conditions

Interventions

TypeNameDescription
DEVICEbioimpedance mesurementsBioimpedance measurements were conducted with a BIS device (SFB7, ImpediMed, Pinkeba, Australia) covering a frequency range between 5 kHz and 1 MHz and an ICG device (Niccomo, medis, Ilmenau, Germany)

Timeline

Start date
2012-07-01
Primary completion
2012-10-01
Completion
2013-10-01
First posted
2013-11-06
Last updated
2013-11-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01977157. Inclusion in this directory is not an endorsement.